APPLICATION
NDA018746
TYPE
NDA
ORIGINAL APPROVAL
1990-04-30
LATEST ACTION
2001-01-02
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
VASOCON-ADiscontinued
ANTAZOLINE PHOSPHATE 0.5%, NAPHAZOLINE HYDROCHLORIDE 0.05% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2001-01-02Manufacturing (CMC) · Supplement 11 · standardAP
1997-03-06Labeling · Supplement 9 · standardAP
1995-08-22Manufacturing (CMC) · Supplement 4 · standardAP
1995-08-03Manufacturing (CMC) · Supplement 7 · standardAP
1995-03-13Labeling · Supplement 8 · standardAP
1994-07-11Efficacy · Supplement 6 · standardAP
1990-09-21Manufacturing (CMC) · Supplement 1 · standardAP
1990-04-30Type 6 - New Indication (no longer used) · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.